See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2017_Alexion_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000899866, Alexion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,578,000,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 9,340,000,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,036,000,000 |
| 3 | remainder_Assets | 299,000,000 |
| 4 | LiabilitiesCurrent | 823,000,000 |
| 5 | LiabilitiesNoncurrent | 2,978,000,000 |
| 6 | remainder_Liabilities | 758,000,000 |
| 7 | CostOfGoodsAndServicesSold | 228,758,126 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,052,113,778 |
| 9 | ResearchAndDevelopmentExpense | 850,271,214 |
| 10 | remainder_Expenses | 1,485,287,750 |
| 11 | remainder_Revenues | 3,947,692,292 |
| 12 | remainder_NetIncome | 7,291,889 |
| 13 | remainder_ComprehensiveNetIncome | 1,048,158 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,253,000,000 |
| 1 | Liabilities | 4,559,000,000 |
| 2 | Expenses | 3,616,430,868 |
| 3 | Revenues | 3,947,692,292 |
| 4 | StockholdersEquity | 8,694,000,000 |
| 5 | NetIncome | 338,553,313 |
| 6 | ComprehensiveNetIncome | 339,077,392 |
| 7 | BaseVar | 12,692,231,604 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.17 |
| 9 | EconomicCapitalRatio | 3.14 |
Edgar->Model Mapping
Feature Distribution
Change over Time
